C12N 5/0043
Medium free of human- or animal-derived components
Official title: {Medium free of human- or animal-derived components}
C12N5/0043 (Medium free of human- or animal-derived components) appears on 113 US grants and 172 published applications in this corpus.
Search patents in C12N- Granted patents
- 113
- Published applications
- 172
- Assignees
- 81
- Inventors
- 257
- Latest grant
- 2 Dec 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 2 | 0 |
| 2001 | 0 | 0 |
| 2002 | 3 | 3 |
| 2003 | 2 | 3 |
| 2004 | 0 | 4 |
| 2005 | 2 | 3 |
| 2006 | 1 | 5 |
| 2007 | 2 | 5 |
| 2008 | 0 | 6 |
| 2009 | 2 | 8 |
| 2010 | 3 | 8 |
| 2011 | 6 | 9 |
| 2012 | 6 | 5 |
| 2013 | 8 | 10 |
| 2014 | 7 | 11 |
| 2015 | 7 | 11 |
| 2016 | 11 | 13 |
| 2017 | 6 | 7 |
| 2018 | 8 | 5 |
| 2019 | 3 | 9 |
| 2020 | 6 | 5 |
| 2021 | 5 | 11 |
| 2022 | 6 | 10 |
| 2023 | 2 | 3 |
| 2024 | 7 | 10 |
| 2025 | 5 | 5 |
| 2026 | 0 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods of culturing a mammalian cell2 Dec 2025US 12,486,524 B2Genzyme Corporation
- Media for culturing stem cells19 Aug 2025US 12,391,918 B2Technion Research & Development Foundation Limited
- Production of proteins in glutamine-free cell culture media8 Jul 2025US 12,351,641 B2Genentech, Inc.
- Serum-free cell culture medium17 Jun 2025US 12,331,341 B2Regeneron Pharmaceuticals, Inc.
- Cell culture media containing combinations of proteins29 Apr 2025US 12,286,467 B2Invitria, Inc.
- Freeze-dried cell culture media and supplements20 Aug 2026US 2026/0242722 A1Life Technologies Corporation
- Adipose-derived regenerative cell preparations21 May 2026US 2026/0139227 A1Blue Cell Therapeutics ApS
- Cultivated animal cells adapted for growth in low amounts, and/or the absence of, direct growth factors, indirect growth factors, animal serum, and/or animal components, and methods of use thereof1 Jan 2026US 2026/0000098 A1
- System and Method for Improved Transient Protein Expression in CHO Cells21 Aug 2025US 2025/0263770 A1Life Technologies Corporation
- Cell culture media containing combinations of proteins7 Aug 2025US 2025/0250323 A1Invitria, Inc.
Most cited
By later US patents
- Method for culturing Chinese hamster ovary cells186US 5,633,162 AGlaxo Wellcome Inc. · 1997
- Mammalian cell culture process for producing glycoproteins149US 6,528,286 B1Genentech, Inc. · 2003
- Recombinant cell clone having increased stability in serum- and protein-free medium and a method of recovering the stable cell clone and the production of recombinant proteins by using a stable cell clone98US 6,100,061 AImmuno Aktiengesellschaft · 2000
- Serum-free medium for culturing animal cells92US 6,406,909 B1Chugai Seiyaku Kabushiki Kaisha · 2002
- Recombinant cell clones having increased stability and methods of making and using the same89US 6,936,441 B2Baxter Aktiengesellschaft · 2005